Replies to post #109 on Amylin Pharmaceuticals Inc. (AMLN)

[mlkrborn]

UPDATE 3-Roche, Ipsen drug faces at least 12-18 month delay
Fri Jun 18, 2010 5:10am EDT

* Roche had previously aimed for regulatory filings in 2011

* Change in clinical trial protocols causes delay

* Follows hypersensitivity reactions in some patients

* Ipsen shares down 15 percent, Roche 2.5 percent; Novo up 3.3 percent (Adds more analyst comment, detail on Roche strategy